{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@id": "https://bio.tools/ADNIGO",
  "@type": "sc:SoftwareApplication",
  "sc:description": "Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.\n\nAlzheimer's Disease Neuroimaging Initiative.\n\nAlzheimer’s Disease Neuroimaging Initiative.\n\nThe Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease (AD). ADNI researchers collect, validate and utilize data, including MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors of the disease. Study resources and data from the North American ADNI study are available through this website, including Alzheimer’s disease patients, mild cognitive impairment subjects, and elderly controls.\n\nClick below to learn more or to join the ADNI study as a participant.\n\n||| COMMON LINK WITH (PUB. & NAME DIFFERENT) bio.tools/LONI-QC (LONI.USC.EDU), bio.tools/ADNI-3 (ADNI.LONI.USC.EDU ; LONI.USC.EDU).\n\n||| CORRECT NAME OF TOOL COULD ALSO BE 'ADNI1', 'ADNI'",
  "sc:name": "ADNIGO",
  "sc:url": "http://adni.loni.ucla.edu/"
}